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Objective. To evaluate oral cavity and pharynx cancer (OCPC) patterns by gender. Methods. We used Surveillance, Epidemiology,
and End Results program data for 71,446 cases diagnosed during 1975–2008 to classify OCPC by anatomic subsite as potentially
H P V - r e l a t e do rn o t ,w i t ho r a lt o n g u ec a n c e rc o n s i d e r e das e p a r a t ec a t e g o ry .Results. Total OCPC rates among men were 2–4 times
those among women. Among whites, total OCPC rates rose in the younger age groups due to substantial increases in successive
birth cohorts for HPV-related cancers, more rapid among men than women, and oral tongue cancers, more rapid among women
than men. Among blacks, total OCPC rates declined among cohorts born since 1930 reﬂecting the strong downward trends for
HPV-unrelated sites. Among Hispanics and Asians, HPV-unrelated cancer rates generally declined, and oral tongue cancer rates
appeared to be converging among young men and women. Conclusions. Decreases in total OCPC incidence reﬂect reductions in
smoking and alcohol drinking. Rising HPV-related cancers among white men may reﬂect changing sexual practices. Reasons for
the increasing young oral tongue cancer rates are unknown, but the narrowing of the gender diﬀerences provides a clue.
1.Introduction
In the United States, incidence rates of oral cavity and
pharynx cancer (OCPC) have been decreasing at about
1% per year over the past decade, with some diﬀerences
according to race, sex, and subsite [1, 2]. Tobacco use is the
major risk factor for these cancers; heavy alcohol drinking is
an independent risk factor and appears to enhance the eﬀect
of smoking [3]. The attributable risk for tobacco and alcohol
use has been estimated at 80% to 90% among US white
andblackmen[3].Dietaryfactors,particularlyconsumption
of fruits and vegetables, have been consistently associated
with reduced risks of OCPC [4]. Oral human papillomavirus
(HPV), particularly HPV 16, is a newly recognized cause of a
subset of OCPC, responsible for 40–80% of oropharyngeal
squamous cell cancers [5–7]. Rising incidence rates for
certain subsites within the oral cavity and pharynx, notably
the base of tongue, tonsil, and oropharynx related to
HPV infection, have been reported in the US particularly
among young white men using data from the Surveillance,
Epidemiology, and End Results (SEER) program [7–14]
and National Program of Cancer Registries [15]. Rising
incidence rates of oral tongue cancer, a subsite not related
to HPV infection, also have been reported, especially among
young white women [16]. To better understand the US inci-
dence patterns, especially diﬀerences by gender, our analysis
updates and extends earlier descriptive studies [11, 12] that
classiﬁed OCPC by anatomic subsite into presumed HPV-
related or HPV-unrelated oral cavity and pharynx cancers
by incorporating cases diagnosed through 2008, considering
oral tongue cancer not related to HPV as a separate category,
including data for Hispanic whites, Asian/Paciﬁc Islanders
(Asian/PIs), and American Indian/Alaskan Natives (AI/ANs)
as well as blacks and non-Hispanic whites, and presenting
age-speciﬁc male/female ratios by year of birth.
2. Methods
Data from population-based registries in the National
Cancer Institute’s Surveillance, Epidemiology, and End2 Journal of Oncology
Results (SEER) program [17, 18] were used to calculate
incidence rates of invasive squamous cell carcinoma (SCC)
(International Classiﬁcation of Diseases for Oncology, 3rd
edition (ICD-O-3) morphology codes 8050-8084) of the
oral cavity (ICD-O-3 topography codes C01.9-C06.9) and
pharynx (codes C09.0-C10.9, C12.9-C14.8) (excluding lip,
salivary glands, and nasopharynx) [19]. Like the classiﬁ-
cation based on anatomic subsite and etiologic relation-
ship with HPV used in two recent publications [11, 12],
we categorized OCPC subsites as presumed HPV-related
or not and then considered HPV-unrelated oral tongue
separately. Speciﬁcally, the HPV-related sites were C01.9-
base of tongue, NOS (not otherwise speciﬁed); C02.4-
lingual tonsil; C09.0-tonsillar fossa; C09.1-tonsillar pillar;
C09.8-overlapping lesion of tonsil; C09.9-tonsil, NOS;
C10.0-vallecula; C10.1-anterior surface of epiglottis; C10.2-
lateral wall of oropharynx; C10.3-posterior wall of orophar-
ynx; C10.4-branchial cleft; C10.8-overlapping lesion of
oropharynx; C10.9-oropharynx, NOS; C14.2-waldeyer ring.
The HPV-unrelated (except oral tongue) sites were: C03.0-
upper gum; C03.1-lower gum; C03.9-gum, NOS; C04.0-
anteriorﬂoorofmouth;C04.1-lateralﬂoorofmouth;C04.8-
overlapping lesion of ﬂoor of mouth; C04.9-ﬂoor of
mouth, NOS; C05.0-hard palate; C05.1-soft palate, NOS;
C05.2-uvula; C05.8-overlapping lesion of palate; C05.9-pal-
ate, NOS; C06.0-cheek mucosa; C06.1-vestibule of mouth;
C06.2-retromolar area; C06.8-overlapping lesion of other
and unspeciﬁed mouth; C06.9-mouth, NOS; C12.9-pyri-
form sinus; C13.0-postcricoid region; C13.1-aryepiglottic
fold, hypopharyngeal; C13.2-posterior wall of hypopharynx;
C13.8-overlapping lesion of hypopharynx; C13.9-hypophar-
ynx, NOS; C14.0-pharynx, NOS; C14.8-overlapping lesion
of lip, oral cavity and pharynx. Lastly, the HPV-unrelated
oral tongue sites were C02.0-dorsal surface of tongue, NOS;
C02.1-border of tongue; C02.2-ventral surface of tongue,
NOS; C02.3-anterior 2/3 of tongue, NOS; C02.8-overlapping
lesion of tongue; C02.9-tongue, NOS.
Data from the original nine SEER registries (SEER 9) for
cases diagnosed during the 34-year period from January 1,
1975, through December 31, 2008, were available for whites
andblacks.Thesenineregistriesarelocatedinthemetropoli-
tan areas of Atlanta, Detroit, San-Francisco-Oakland, and
Seattle-Puget Sound and the states of Connecticut, Hawaii,
Iowa, New Mexico, and Utah. For cases diagnosed during
1992–2008, data were available for the racial groups of
whites, blacks, Asian/PIs, and AI/ANs and whether of
Hispanic origin in the SEER 13, which includes the SEER 9
plus four additional areas, the California metropolitan areas
of San Jose-Monterey and Los Angeles, rural Georgia, and
Alaska Natives in Alaska. In the recent years 2004–2008, the
SEER 9 and 13 registries accounted for about 10% and 14%
of the US population, respectively [1]. All SEER registries
annually meet the Gold Standard Registry Certiﬁcation
from the North American Association of Central Cancer
Registries, Inc. for completeness (at least 95%), accuracy
(<3% of cases identiﬁed through death certiﬁcates only),
and timeliness of data. Age-adjusted incidence rates per
100,000 person-years of OCPC (using the 2000 US standard)
were calculated for each subsite category (total, HPV-related,
HPV-unrelated, and oral tongue) by sex and race/ethnicity
using SEER∗Stat [20]. All 95% conﬁdence intervals (CIs)
wereestimatedusingtheTiwarimodiﬁcation[21].Incidence
rate ratios (IRRs) were calculated using females as the
referent group.
Temporal trends in age-adjusted incidence rates using
ﬁve- or six-year time periods 1975–79, 1980–85, 1986–91,
1992–97, 1998–2003, and 2004–2008 were plotted according
to year of diagnosis by race/ethnicity, subsite category,
and sex. Temporal trends in age-speciﬁc rates were plotted
according to year of birth to facilitate visual comparison of
rates. The year of birth was derived by subtracting age at
diagnosis (midpoint of age group, i.e., 35 for age group 25–
44, 50 for age group 45–54, 60 for age group 55–64, and
77.5 for age group 65+) from calendar year of diagnosis
(midpointofthecalendarperiod);thecohortsarereferredto
bytheirapproximatemidyearofbirth.Onlyratesbasedonat
least 10 cases were presented. Temporal trends were plotted
so that a slope of 10 degrees represented a change of 1% per
year (i.e., 40 years on the horizontal axis is the same length
as one logarithmic cycle on the vertical axis) [22]. Estimates
of annual percent changes (EAPCs) were calculated for the
period 1985–2008 using weighted least squares.
3. Results
There were 27,767 cases (18,573 men and 9,194 women) of
OCPC diagnosed among whites and blacks during 1975–
1991 in the SEER 9 and 43,679 cases (30,068 men and 13,611
women) among whites (non-Hispanic), blacks, Hispanics
(white), Asian/PIs, and AI/ANs during 1992–2008 in the
SEER 13 (Table 1). Total OCPC rates among men were 2–
4 times those among women across each race/ethnicity and
time period. Male/female (MF) IRRs for 1992–2008 SEER
13 were highest among blacks for each subsite (IRR = 2.60–
4.32) and lowest among Asian/PIs (IRR = 2.39) for total,
whites for HPV-related (IRR = 3.98) and HPV-unrelated
(IRR = 2.16), and AI/ANs for oral tongue (IRR = 0.88, the
only IRR not signiﬁcantly higher than 1.0). The MF IRR
for HPV-related cases (recent range 3.98–4.47) was higher
than that for HPV-unrelated cases (recent range 2.16–3.37)
inallinstancesexcept1975–1991SEER9blacks.TheMFIRR
for oral tongue (recent range 0.88–2.77) was smaller than
that for other HPV-unrelated cases among each racial/ethnic
group. Among whites and blacks in the SEER 9, the MF IRRs
increased from 1975–1991 to 1992–2008 for HPV-related
sites, but declined for HPV-unrelated sites and oral tongue.
Trends in the age-adjusted OCPC incidence rates by
race/ethnicity (whites (non-Hispanic), blacks, Hispanics
(white), and Asian/PIs), subsite category, and gender in the
SEER 13 during 1992–2008 are presented in Figure 1.F o r
historical purposes, trend data for whites and blacks in the
SEER 9 are also shown for 1975–2008. As seen in Figure 1,
the two sets of rates in recent years were similar except for
oral tongue among blacks where the rates were somewhat
higher in the SEER 13 than the 9. Because the rates are
based on larger numbers of cases and thus are more stable
in the SEER 13 than the SEER 9, we will focus on them.Journal of Oncology 3
T
a
b
l
e
1
:
S
q
u
a
m
o
u
s
c
e
l
l
c
a
r
c
i
n
o
m
a
o
f
t
h
e
o
r
a
l
c
a
v
i
t
y
a
n
d
p
h
a
r
y
n
x
i
n
c
i
d
e
n
c
e
b
y
t
i
m
e
p
e
r
i
o
d
,
r
a
c
e
/
e
t
h
n
i
c
i
t
y
,
s
e
x
,
a
n
d
s
u
b
s
i
t
e
.
Y
e
a
r
o
f
d
i
a
g
n
o
s
i
s
S
E
E
R
a
r
e
a
s
R
a
c
e
/
e
t
h
n
i
c
i
t
y
S
e
x
T
o
t
a
l
H
P
V
-
r
e
l
a
t
e
d
H
P
V
-
u
n
r
e
l
a
t
e
d
O
r
a
l
t
o
n
g
u
e
C
a
s
e
s
r
a
t
e
/
r
a
t
i
o
(
9
5
%
C
I
)
C
a
s
e
s
r
a
t
e
/
r
a
t
i
o
(
9
5
%
C
I
)
C
a
s
e
s
r
a
t
e
/
r
a
t
i
o
(
9
5
%
C
I
)
C
a
s
e
s
r
a
t
e
/
r
a
t
i
o
(
9
5
%
C
I
)
1
9
7
5
–
1
9
9
1
9
A
l
l
w
h
i
t
e
s
M
a
l
e
F
e
m
a
l
e
1
5
,
9
7
9
8
,
3
4
3
1
2
.
3
5
.
2
(
1
2
.
1
,
1
2
.
5
)
(
5
.
1
,
5
.
3
)
4
,
6
8
2
2
,
2
2
7
3
.
6
1
.
4
(
3
.
5
,
3
.
7
)
(
1
.
3
,
1
.
4
)
8
,
8
7
6
4
,
5
9
7
6
.
9
2
.
8
(
6
.
7
,
7
.
0
)
(
2
.
8
,
2
.
9
)
2
,
4
2
1
1
,
5
1
9
1
.
9
0
.
9
(
1
.
8
,
1
.
9
)
(
0
.
9
,
1
.
0
)
1
9
7
5
–
1
9
9
1
9
B
l
a
c
k
s
M
a
l
e
F
e
m
a
l
e
2
,
5
9
4
8
5
1
2
2
.
6
5
.
9
(
2
1
.
7
,
2
3
.
5
)
(
5
.
5
,
6
.
4
)
9
0
1
3
0
0
7
.
8
2
.
1
(
7
.
3
,
8
.
4
)
(
1
.
9
,
2
.
3
)
1
,
4
4
2
4
5
2
1
2
.
6
3
.
2
(
1
2
.
0
,
1
3
.
3
)
(
2
.
9
,
3
.
5
)
2
5
1
9
9
2
.
2
0
.
7
(
1
.
9
,
2
.
5
)
(
0
.
6
,
0
.
9
)
1
9
9
2
–
2
0
0
8
9
A
l
l
w
h
i
t
e
s
M
a
l
e
F
e
m
a
l
e
1
8
,
5
3
9
8
,
5
3
3
1
1
.
2
4
.
4
(
1
1
.
1
,
1
1
.
4
)
(
4
.
3
,
4
.
4
)
8
,
2
9
3
2
,
3
5
2
4
.
9
1
.
2
(
4
.
8
,
5
.
0
)
(
1
.
2
,
1
.
3
)
7
,
1
5
5
4
,
0
0
9
4
.
4
2
.
0
(
4
.
3
,
4
.
5
)
(
1
.
9
,
2
.
1
)
3
,
0
9
1
2
,
1
7
2
1
.
9
1
.
1
(
1
.
8
,
2
.
0
)
(
1
.
1
,
1
.
2
)
1
9
9
2
–
2
0
0
8
9
B
l
a
c
k
s
M
a
l
e
F
e
m
a
l
e
2
,
7
1
1
9
3
4
1
5
.
5
4
.
2
(
1
4
.
9
,
1
6
.
2
)
(
3
.
9
,
4
.
5
)
1
,
2
2
2
3
4
9
6
.
8
1
.
5
(
6
.
4
,
7
.
2
)
(
1
.
4
,
1
.
7
)
1
,
2
4
5
4
6
9
7
.
3
2
.
2
(
6
.
9
,
7
.
7
)
(
2
.
0
,
2
.
4
)
2
4
4
1
1
6
1
.
4
0
.
5
(
1
.
2
,
1
.
6
)
(
0
.
4
,
0
.
6
)
1
9
9
2
–
2
0
0
8
1
3
W
h
i
t
e
s
(
n
o
n
-
H
i
s
p
a
n
i
c
)
M
a
l
e
F
e
m
a
l
e
2
2
,
6
5
7
1
0
,
5
8
6
1
1
.
6
4
.
5
(
1
1
.
5
,
1
1
.
8
)
(
4
.
5
,
4
.
6
)
1
0
,
3
3
6
2
,
9
5
5
5
.
2
1
.
3
(
5
.
1
,
5
.
3
)
(
1
.
3
,
1
.
4
)
8
,
5
5
3
4
,
9
3
6
4
.
5
2
.
1
(
4
.
4
,
4
.
6
)
(
2
.
0
,
2
.
1
)
3
,
7
6
8
2
,
6
9
5
2
.
0
1
.
2
(
1
.
9
,
2
.
0
)
(
1
.
1
,
1
.
2
)
1
9
9
2
–
2
0
0
8
1
3
B
l
a
c
k
s
M
a
l
e
F
e
m
a
l
e
3
,
6
9
0
1
,
3
1
1
1
5
.
1
4
.
2
(
1
4
.
6
,
1
5
.
6
)
(
4
.
0
,
4
.
4
)
1
,
6
4
9
4
8
6
6
.
6
1
.
5
(
6
.
3
,
7
.
0
)
(
1
.
4
,
1
.
7
)
1
,
6
6
3
6
3
1
6
.
9
2
.
1
(
6
.
6
,
7
.
3
)
(
1
.
9
,
2
.
2
)
3
7
8
1
9
4
1
.
6
0
.
6
(
1
.
4
,
1
.
7
)
(
0
.
5
,
0
.
7
)
1
9
9
2
–
2
0
0
8
1
3
H
i
s
p
a
n
i
c
s
(
w
h
i
t
e
)
M
a
l
e
F
e
m
a
l
e
1
,
8
9
5
7
9
1
6
.
8
2
.
4
(
6
.
5
,
7
.
1
)
(
2
.
3
,
2
.
6
)
7
7
9
2
1
7
2
.
6
0
.
6
(
2
.
4
,
2
.
8
)
(
0
.
6
,
0
.
7
)
8
0
3
3
0
3
3
.
0
1
.
0
(
2
.
8
,
3
.
3
)
(
0
.
9
,
1
.
1
)
3
1
3
2
7
1
1
.
1
0
.
8
(
1
.
0
,
1
.
3
)
(
0
.
7
,
0
.
9
)
1
9
9
2
–
2
0
0
8
1
3
A
s
i
a
n
/
P
I
s
M
a
l
e
F
e
m
a
l
e
1
,
6
5
5
8
4
7
5
.
9
2
.
5
(
5
.
6
,
6
.
2
)
(
2
.
3
,
2
.
6
)
5
2
8
1
5
3
1
.
8
0
.
4
(
1
.
7
,
2
.
0
)
(
0
.
4
,
0
.
5
)
6
8
3
3
1
0
2
.
5
0
.
9
(
2
.
3
,
2
.
7
)
(
0
.
8
,
1
.
0
)
4
4
4
3
8
4
1
.
5
1
.
1
(
1
.
4
,
1
.
7
)
(
1
.
0
,
1
.
2
)
1
9
9
2
–
2
0
0
8
1
3
A
I
/
A
N
s
M
a
l
e
F
e
m
a
l
e
1
7
1
7
6
5
.
9
2
.
3
(
5
.
0
,
6
.
9
)
(
1
.
8
,
2
.
9
)
7
2
1
8
2
.
2
0
.
5
(
1
.
7
,
2
.
8
)
(
0
.
3
,
0
.
8
)
8
1
3
5
3
.
1
1
.
1
(
2
.
4
,
4
.
0
)
(
0
.
8
,
1
.
5
)
1
8
2
3
0
.
6
0
.
7
(
0
.
3
,
0
.
9
)
(
0
.
4
,
1
.
0
)
M
a
l
e
/
f
e
m
a
l
e
I
R
R
s
:
1
9
7
5
–
1
9
9
1
9
A
l
l
w
h
i
t
e
s
2
.
3
8
(
2
.
3
2
,
2
.
4
4
)
2
.
5
7
(
2
.
4
5
,
2
.
7
1
)
2
.
4
2
(
2
.
3
4
,
2
.
5
1
)
1
.
9
6
(
1
.
8
4
,
2
.
0
9
)
1
9
7
5
–
1
9
9
1
9
B
l
a
c
k
s
3
.
8
0
(
3
.
5
2
,
4
.
1
1
)
3
.
7
3
(
3
.
2
7
,
4
.
2
5
)
4
.
0
0
(
3
.
6
0
,
4
.
4
5
)
3
.
1
1
(
2
.
4
6
,
3
.
9
3
)
1
9
9
2
–
2
0
0
8
9
A
l
l
w
h
i
t
e
s
2
.
5
8
(
2
.
6
8
,
2
.
7
6
)
3
.
9
9
(
4
.
6
8
,
5
.
1
9
)
2
.
2
2
(
1
.
7
3
,
1
.
9
3
)
1
.
6
9
(
1
.
6
0
,
1
.
8
5
)
1
9
9
2
–
2
0
0
8
9
B
l
a
c
k
s
3
.
7
0
(
3
.
4
3
,
3
.
9
9
)
4
.
4
7
(
3
.
9
7
,
5
.
0
3
)
3
.
3
7
(
3
.
0
3
,
3
.
7
5
)
2
.
7
7
(
2
.
2
2
,
3
.
4
6
)
1
9
9
2
–
2
0
0
8
1
3
W
h
i
t
e
s
(
n
o
n
-
H
i
s
p
a
n
i
c
)
2
.
5
6
(
2
.
5
0
,
2
.
6
2
)
3
.
9
8
(
3
.
8
2
,
4
.
1
4
)
2
.
1
6
(
2
.
0
9
,
2
.
2
4
)
1
.
6
7
(
1
.
5
9
,
1
.
7
5
)
1
9
9
2
–
2
0
0
8
1
3
B
l
a
c
k
s
3
.
6
1
(
3
.
3
9
,
3
.
8
4
)
4
.
3
2
(
3
.
9
1
,
4
.
7
8
)
3
.
3
7
(
3
.
0
7
,
3
.
6
9
)
2
.
6
0
(
2
.
1
9
,
3
.
0
9
)
1
9
9
2
–
2
0
0
8
1
3
H
i
s
p
a
n
i
c
s
(
w
h
i
t
e
)
2
.
7
7
(
2
.
5
5
,
3
.
0
1
)
4
.
1
1
(
3
.
5
4
,
4
.
7
8
)
2
.
9
9
(
2
.
6
2
,
3
.
4
1
)
1
.
4
3
(
1
.
2
1
,
1
.
6
8
)
1
9
9
2
–
2
0
0
8
1
3
A
s
i
a
n
/
P
I
s
2
.
3
9
(
2
.
2
0
,
2
.
6
0
)
4
.
2
1
(
3
.
5
2
,
5
.
0
4
)
2
.
6
8
(
2
.
3
5
,
3
.
0
7
)
1
.
4
1
(
1
.
2
3
,
1
.
6
2
)
1
9
9
2
–
2
0
0
8
1
3
A
I
/
A
N
s
2
.
5
9
(
1
.
9
7
,
3
.
3
9
)
4
.
1
4
(
2
.
4
7
,
6
.
9
4
)
2
.
8
5
(
1
.
9
2
,
4
.
2
4
)
0
.
8
8
(
0
.
4
7
,
1
.
6
3
)
O
r
a
l
c
a
v
i
t
y
a
n
d
p
h
a
r
y
n
x
e
x
c
l
u
d
e
s
l
i
p
,
s
a
l
i
v
a
r
y
g
l
a
n
d
s
,
a
n
d
n
a
s
o
p
h
a
r
y
n
x
.
H
P
V
-
r
e
l
a
t
e
d
i
n
c
l
u
d
e
s
b
a
s
e
o
f
t
o
n
g
u
e
,
l
i
n
g
u
a
l
t
o
n
s
i
l
,
t
o
n
s
i
l
,
o
r
o
p
h
a
r
y
n
x
,
a
n
d
W
a
l
d
e
y
e
r
r
i
n
g
.
O
r
a
l
t
o
n
g
u
e
i
n
c
l
u
d
e
s
d
o
r
s
a
l
a
n
d
v
e
n
t
r
a
l
s
u
r
f
a
c
e
s
,
b
o
r
d
e
r
,
a
n
t
e
r
i
o
r
2
/
3
,
o
v
e
r
l
a
p
p
i
n
g
l
e
s
i
o
n
s
,
a
n
d
t
o
n
g
u
e
n
o
t
o
t
h
e
r
w
i
s
e
s
p
e
c
i
ﬁ
e
d
.
R
a
t
e
s
p
e
r
1
0
0
,
0
0
0
p
e
r
s
o
n
-
y
e
a
r
s
,
a
g
e
-
a
d
j
u
s
t
e
d
u
s
i
n
g
t
h
e
U
S
2
0
0
0
p
o
p
u
l
a
t
i
o
n
s
t
a
n
d
a
r
d
;
9
5
%
C
I
=
9
5
%
c
o
n
ﬁ
d
e
n
c
e
i
n
t
e
r
v
a
l
.
I
R
R
s
:
i
n
c
i
d
e
n
c
e
r
a
t
e
r
a
t
i
o
s
,
b
a
s
e
d
o
n
u
n
r
o
u
n
d
e
d
r
a
t
e
s
.
A
s
i
a
n
/
P
I
s
:
A
s
i
a
n
/
P
a
c
i
ﬁ
c
I
s
l
a
n
d
e
r
s
.
A
I
/
A
N
s
:
A
m
e
r
i
c
a
n
I
n
d
i
a
n
/
A
l
a
s
k
a
N
a
t
i
v
e
s
.4 Journal of Oncology
1980 1995 2010
0.1
1
10
30
1980 1995 2010
0.1
1
10
30
1980 1995 2010
0.1
1
10
30
1980 1995 2010
0.1
1
10
30
1980 1995 2010
0.1
1
10
30
1980 1995 2010
0.1
1
10
30
1980 1995 2010
0.1
1
10
30
1980 1995 2010
0.1
1
10
30
1980 1995 2010
0.1
1
10
30
1980 1995 2010
0.1
1
10
30
1980 1995 2010
0.1
1
10
30
1980 1995 2010
0.1
1
10
30
1980 1995 2010
0.1
1
10
30
1980 1995 2010
0.1
1
10
30
1980 1995 2010
0.1
1
10
30
1980 1995 2010
0.1
1
10
30
SEER 9 SEER 13
Male
Female
Oral tongue HPV-unrelated HPV-related Total
r
a
t
e
 
p
e
r
 
1
0
0
.
0
0
0
 
p
e
r
s
o
n
-
y
e
a
r
s
A
s
i
a
n
/
P
a
c
i
ﬁ
c
 
I
s
l
a
n
d
e
r
s
r
a
t
e
 
p
e
r
 
1
0
0
.
0
0
0
 
p
e
r
s
o
n
-
y
e
a
r
s
H
i
s
p
a
n
i
c
s
 
(
w
h
i
t
e
)
r
a
t
e
 
p
e
r
 
1
0
0
.
0
0
0
 
p
e
r
s
o
n
-
y
e
a
r
s
B
l
a
c
k
s
r
a
t
e
 
p
e
r
 
1
0
0
.
0
0
0
 
p
e
r
s
o
n
-
y
e
a
r
s
W
h
i
t
e
s
Figure 1: Trends in age-adjusted (2000 US standard) squamous cell carcinoma of the oral cavity and pharynx incidence rates by
race/ethnicity, subsite, and gender for whites and blacks SEER 9 1975–1979 to 2004–2008 and for whites (non-Hispanic), blacks, Hispanics
(white), and Asian/PIs SEER 13 1992–1997 to 2004–2008 according to year of diagnosis (excludes lip, salivary glands, and nasopharynx).
Shaded bands portray 95% conﬁdence intervals.Journal of Oncology 5
Furthermore, it is increasingly important to distinguish non-
Hispanics and Hispanics among whites because their rates
arequitediﬀerent,andthepopulationproportionshavebeen
changingovertime.Thus,wewillusethetermwhitestorefer
to whites in the SEER 9 1975–1991 and white non-Hispanics
in the SEER 13 1992–2008, blacks in the SEER 9 early years
and SEER 13 recent years, and Hispanics for Hispanic whites
and Asians for Asian/PIs in the SEER 13 recently. Among
whites,totalratesformenpeakedat12.7per100,000person-
years in 1980–1985 before declining gradually (11%) to 11.3
in 1998–2003 and then rose 5% to 12.0 in 2004–2008. Rates
among women also peaked in 1980–1985 at 5.4 and declined
more rapidly (20%) to 4.3 in 2004–2008. Among blacks,
total rates for both men and women peaked during 1980–
1985 and then declined dramatically until 2004–2008, by
48% from 23.7 to 12.3 among males and by 43% from 6.5 to
3.7 among females. During the recent 17-year period, total
rates decreased signiﬁcantly among all racial/ethnic/gender
groups except white men.
HPV-related rates among white men rose 88% from
3.4 in 1975–1979 to 6.4 in 2004–2008, more rapidly in
recent years than earlier, while HPV-unrelated rates declined
50% from 7.2 in 1980–1985 to 3.6 in 2004–2008 (Figure 1).
Among the other race/sex groups, rates for HPV-related
sites generally decreased or changed little. HPV-unrelated
rates declined sharply among all race/sex groups, similar to
white males. Rates decreased from 1980–1985 to 2004–2008
among white females by 43% from 3.0 to 1.7 and among
blacks even more rapidly, by 64% among men from 13.3
to 4.8, and by 48% among females from 3.3 to 1.7. Rates
also declined rapidly among Hispanics (men 34%, women
49%) and Asians (men 34%, women 28%) during 1992–
2008. Oral tongue cancer rates among white men varied
little over time, whereas rates in white women increased 44%
from 0.9 in 1975–1979 to 1.3 in 2004–2008. Rates rose more
rapidly among females than males among Hispanics (men
10%, women 45%) and Asians (men 19%, women 26%). In
contrast, rates among blacks declined 50% for males (from
2.4 in 1980–1985 to 1.2 in 2004–2008) and 33% for females
(from 0.9 in 1975–1979 to 0.6 in 2004–2008). The EAPCs
from 1985 to 2008 among white males were +2.9% for
HPV-related cancers and −3.1% for HPV-unrelated cancers,
among white females −2.7% for HPV-unrelated cancers and
+1.1% for oral tongue cancers, and among blacks for HPV-
unrelated cancers −4.9% and −2.9% for males and females,
respectively.
The MF IRRs among whites doubled from 2.4 to 4.8 for
HPV-related cancers declined modestly from 2.4 to 2.1 for
HPV-unrelated cancers, and moderately from 2.0 to 1.5 for
oral tongue cancers. Among blacks, the decrease in MF IRR
for HPV-unrelated cancers was quite rapid, from 4.0 to 2.8.
Among whites, total rates rose in the youngest age group
among men and women due to substantial increases in
successive birth cohorts for HPV-related cancers, more rapid
among men than women, and oral tongue cancers, more
rapid among women than men (Figure 2). The HPV-related
rates among men aged 25–44 years more than tripled from
0.4 per 100,000 man-years in the 1942 birth cohort to 1.5
in the 1972 cohort, and rates among men aged 45–54 years
morethandoubledfrom5.3forthe1939 birthcohortto12.8
for the 1956 birth cohort; rates also rose among men 55–64
from 12.5 for the 1923 cohort to 23.0 for the 1946 cohort.
The EAPCs among men aged 25–64 each were >3%. Among
women, HPV-related rates for the older age groups did not
vary greatly in successive birth cohorts. For HPV-unrelated
cancers, rates among white men declined 67% (from 0.9 to
0.3), 54% (from 9.2 to 4.2), 59% (from 23.9 to 9.7), and
42%(from28.6to16.5)amongthoseaged25–44,45–54,55–
64, and 65+ years, respectively; the EAPCs ranged between
−3.1% and −4.0% among all but the oldest. Rates among
womenalsodeclined37%(from0.27to0.17),66%(from4.1
to 1.4), 66% (from 9.8 to 3.3), and 24% (from 12.2 to 9.3),
respectively. Oral tongue cancer rates among women aged
25–44yearsmorethantripledat+3.4%peryearfrom0.2per
100,000 woman-years in the 1942 birth cohort to 0.7 in the
1972 cohort where rates approached those for young men,
among whom rates increased 71% over the 30-year time
period. Oral tongue rates also rose among women aged 45–
54 years born since 1940 but not among men; rates for men
or women in the older age groups did not change greatly.
Among blacks, total rates declined among cohorts born
since at least 1930 reﬂecting the strong downward trends
among men and women especially for HPV-unrelated sites
(Figure 2).Blackmenaged25–44experiencedthemostrapid
decrease in rates for HPV-unrelated sites across successive
birth cohorts, 82% (from 4.5 to 0.8); and rates among males
aged 45–54, 55–64, and 65+ years also declined impressively,
76% (from 28.3 to 6.8), 74% (from 51.1 to 13.4), and 43%
(33.5 to 19.2), respectively. The corresponding EAPCs were
−7.4% among those aged 25–44, and −6.8%, −5.5%, and
−2.7% among the oldest. Rates decreased notably among
women aged 25–44 (78%), 45–54 (76%), and 55–64 (64%),
but not among women aged 65+. Oral tongue cancer
rates among men generally declined across successive birth
cohorts except for the older age groups where rates were
relatively stable; in recent years among the youngest age
group, the male predominance was no longer apparent. Of
note, there was no suggestion of rapid increases in rates of
HPV-related or oral tongue cancers among young blacks as
seen among whites.
Among Hispanics and Asians, total OCPC trends were
not consistent across the genders or age groups. However,
rates of HPV-unrelated cancer generally declined across
successivebirth cohorts forboth genders. Oral tongue cancer
rates appeared to be converging among young men and
women of both groups.
The MF IRRs for total among whites remained about 2
amongthosebornpriorto1940,afterwhichtheyroseto2.9–
3.8 among those born during the 1950s and then declined
to 2.3 among those born around 1970 (Figure 3). MF IRRs
for HPV-related cases were higher, hovering between 2 and
3 among those born prior to 1930, after which they rose to
almost 6 among those aged 45–64 years born during the late
1940s–1950s; among those aged 25–44, the IRR rose from
1.9 among those born in the early 1940s to about 4 among
those born since the mid-1950s. The MF IRRs for HPV-
unrelated cases varied less by age group and year of birth,6 Journal of Oncology
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Figure 2:Trendsinage-speciﬁcsquamouscellcarcinomaoftheoralcavityandpharynxincidenceratesbyrace/ethnicity,subsite,andgender
for whites and blacks SEER 9 1975–1979 to 1986–1991 and for whites (non-Hispanic), blacks, Hispanics (white), and Asian/PIs SEER 13
1992–2008 according to year of birth (excludes lip, salivary glands, and nasopharynx) (rates age-adjusted within age group).Journal of Oncology 7
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Figure 3: Trends in age-speciﬁc squamous cell carcinoma of the oral cavity and pharynx male/female incidence rate ratios among whites
by subsite SEER 9 1975–1979 to 1986–1991 and whites (non-Hispanic) SEER 13 1992–2008 according to year of birth (excludes lip, salivary
glands, and nasopharynx).
ranging between 2 and 3 among those born prior to the mid-
1940s, rising to between 3 and 4 among those born during
the 1950s and falling back to 3 or lower subsequently. Oral
tongue cancer IRRs were all <3; among both the oldest and
the youngest age groups, the IRRs decreased from about 2 to
1.3-1.4 over the study period.
4. Discussion
In this study, we analyzed temporal trends of total OCP,
presumed HPV-related, presumed HPV-unrelated, and oral
tongue cancer among US men and women of white, black,
Hispanic, Asian, and AI/AN ethnicity. Our study, which
highlights changing patterns by gender, is based on the
same categorization of anatomic subsites as presumed HPV-
related or not used in two recent publications [11, 12],
and we extend these ﬁndings by classifying cancer of the
oral tongue separately from other HPV-unrelated sites,
incorporating cases diagnosed through 2008, increasing the
studypopulationbyincludingdatafromSEER13,classifying
whitesasHispanicornon-Hispanic,andpresentingMFIRRs
overall and by year of birth.
Similar to other studies, we found overall OCPC inci-
dence rates among men to be 2–4 times those among women
of all race/ethnicities, and in recent decades, they varied
from 4 or greater for HPV-related sites to 2-3 for HPV-
unrelated sites, and 1–3 for oral tongue cancer. The MF IRR
for HPV-related sites doubled among whites from 2.4 to 4.8
over the study period, due especially to rapidly rising rates8 Journal of Oncology
of HPV-related OCPC among white men, particularly those
born since 1940. Consistent decreases in the MF IRRs for
HPV-unrelated sites were observed for whites (from 2.4 to
2.1) and blacks (from 4.0 to 2.8), due to rapidly declining
rates especially among black men born since 1940. The IRRs
for oral tongue cancer generally declined among all ethnic
groups due especially to rising rates among younger white,
Hispanic, and Asian women. Total OCPC trends varied
markedly over the period 1985–2008. The age-adjusted rates
for HPV-related cancers rose 3% per year among white
males, for HPV-unrelated cancers declined 3% per year
among whites of both genders and black females and 5% per
year among black males, and for oral tongue cancer rose 1%
p e ry e a ra m o n gw h i t ef e m a l e s .
The declines seen in HPV-unrelated cancer for all race/
ethnic-sex groups are consistent with a pathway mainly
driven by alcohol and tobacco (potentially related to p53 or
other molecular alterations [23]) that parallel the reductions
in US cigarette smoking prevalence [24] and may also
reﬂect decreases in national per capita alcohol consumption,
especially the use of hard liquor [25]. The steep declines
in SCC of the OCP and racial/gender patterns seen here
resemble the patterns for SCC of the esophagus, which also
reﬂectthetrendsincigarettesmokingprevalenceandalcohol
consumption [26].
Among white males, the much smaller declines in the
incidence of total OCPC appear to be driven by the rising
incidence of HPV-related cancers, in contrast to the declines
in HPV-unrelated cancers [27–29]. A number of studies
have documented the increasing prevalence of HPV in
oropharyngeal cancers during the past 30 years. In the
US, the prevalence of HPV in oropharyngeal cancers rose
from 33% during the 1980s to 70% in the 1990s and 82%
during 2000–2004, based on 72 cases assayed in Colorado
[10] and from 16% during the 1980s to 73% during the
2000s based on 271 cases from SEER tissue repositories
in Hawaii, Iowa, and Los Angeles [13]. During the 2000s,
s e v e r a lg r o u p sh a v er e p o r t e dH P Vp r e v a l e n c er a t e sa m o n g
oropharynx, tongue, and tonsil cases ranging from 63% to
92%, whereas the prevalence among other oral cancers has
been20%orless[30–32].Thus,ourassignmentofpresumed
HPV status based on anatomic subsite certainly included
non-HPV-related cases, more so during the earlier years
compared to more recently. The incidence data suggest that
the proportions also varied by gender, racial/ethnic group,
and age.
HPV is a very common sexually transmitted infection
in the United States [33]. Data from the 2003-2004 National
Health and Nutrition Examination Survey (NHANES) re-
linebreak vealed that the seroprevalence of any HPV types
6, 11, 16, or 18 (types in the quadrivalent vaccine) among
persons aged 14–59 years was 22.4% overall, higher among
females (32.5%) than males (12.1%), peaked at 42.0%
among females aged 30–39 years and 18.0% among males
aged 50–59 years, and was associated with lifetime number
of sexual partners, especially among females [34]. About
90% of both females and males aged 25–44 ever had oral
sex with an opposite-sex partner, based on data from the
2006–2008 National Survey of Family Growth (NSFG) [35].
The prevalence of oral infection with any of 37 HPV DNA
types during 2009-2010 was 6.9% among those aged 14–
69, signiﬁcantly higher among men (10.1%) than women
(3.6%), and increased with the number of sexual partners
and cigarettes smoked per day, based on NHANES data [36].
Similar to other recent studies of oral tongue cancer
[16, 37], we found increasing rates among young white
adults aged 25–44 that were more rapid for women than
for men, and some suggestion of similar patterns among
blacks, Hispanics, and Asians. The causal pathway for oral
tongue cancer in these patients is not known, but it does
not appear to be related to use of alcohol or tobacco [16]
or to the presence of HPV [16, 37]. Its unique age- and sex-
speciﬁcincidencepatternssuggestthatitmayhaveadiﬀerent
etiology from other OCPCs [37] including other oncogenic
viruses, bacteria, and lifestyle and environmental factors.
A limitation of our descriptive study is that HPV status is
based on a categorization by anatomic subsite and thus likely
resultedinsomemisclassiﬁcationofactualHPVstatus.Ithas
been suggested that HPV-related base of the tongue cancer
may have been misclassiﬁed as oral tongue [11, 16]; however,
the MF IRRs appear to be very diﬀerent [37]. Cases without
a particular site of the tongue speciﬁed (coded C02.9 =
tongue, not otherwise speciﬁed) accounted for about 15% of
oral tongue cases among whites during 1975–2008, and the
proportion rose from 13% during 1975–1979 to 17% during
2004–2008. To the extent that some of these may have been
HPV-related, then the observed increases in HPV-related
cancers among white males have been underestimated. The
observed increases in HPV-unrelated oral tongue cancer
among white females may have been overstated; however,
r a t e sf o re a c hs p e c i ﬁ ct o n g u es u b s i t ea sw e l la st o n g u e ,N O S ,
all rose.
In summary, our large numbers based on SEER 13
allowed us to plot race-, sex-, and age-speciﬁc incidence
r a t e so fO C P Cb yH P Vc a t e g o r ya n dy e a ro fb i r t ha n d
to carry out a detailed analysis of oral tongue cancers.
The signiﬁcant decreases in total OCPC incidence seen for
most race/sex groups reﬂect reductions in smoking preva-
lence due to public health eﬀorts aimed at cessation and
lowering initiation rates as well as decreases in alcohol con-
sumption. The increasing rates of cancer of the oral tongue
especially among young men and women is of growing
concern and suggest the need for dedicated research into the
epidemiology of these understudied tumors; the narrowing
of the gender diﬀerences apparent across all the racial/ethnic
groups provides a clue worthy of pursuit. The much smaller
decline in total OCPC incidence and recent increases among
white men born since the mid-1940s appear related to
the rapidly rising rates of HPV-related cancers and may
reﬂect changes in sexual practices since the mid-1960s. The
potential impact of HPV vaccination recently approved for
both girls and boys on these trends is unknown, but changes
are likely many years in the future. Dentists and physicians
need to be aware of the notable and signiﬁcant rise in rates
of cancers of the oral tongue and HPV-related cancers of
the oropharynx, especially among young men and women,Journal of Oncology 9
and ensure that these new at-risk groups receive routine oral
cancer screening.
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